Value Management+research buy krebskrebs
Start price
02.10.23
/
50%
€1.62
Target price
02.10.24
€2.00
Performance (%)
-20.37%
End price
03.10.24
-
Summary
This prediction is currently being closed. The prediction for Value Management+research disappoints with a performance of -20.37%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Value Management+research | - | - | - |
| iShares Core DAX® | -0,38 % | 1,09 % | 11,64 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % | 7,27 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % | 31,38 % |
| iShares S&P 500 | -0,71 % | 0,44 % | 4,30 % |
Comments by krebskrebs for this prediction
In the thread Value Management+research diskutieren
Buy mit Kursziel 2,0
In the thread Trading Value Management+research
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

